TH65953B - Prevention and treatment of asymptomatic PCVD - Google Patents
Prevention and treatment of asymptomatic PCVDInfo
- Publication number
- TH65953B TH65953B TH801000690A TH0801000690A TH65953B TH 65953 B TH65953 B TH 65953B TH 801000690 A TH801000690 A TH 801000690A TH 0801000690 A TH0801000690 A TH 0801000690A TH 65953 B TH65953 B TH 65953B
- Authority
- TH
- Thailand
- Prior art keywords
- pcv2
- asymptomatic
- animals
- infection
- antigens
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title claims abstract 5
- 201000009910 diseases by infectious agent Diseases 0.000 claims abstract 20
- 241001465754 Metazoa Species 0.000 claims abstract 18
- 239000000427 antigen Substances 0.000 claims abstract 18
- 102000038129 antigens Human genes 0.000 claims abstract 18
- 108091007172 antigens Proteins 0.000 claims abstract 18
- 241000282887 Suidae Species 0.000 claims abstract 9
- 241000282898 Sus scrofa Species 0.000 claims abstract 5
- 239000000470 constituent Substances 0.000 claims abstract 2
- 101700047669 ORF2 Proteins 0.000 claims 10
- 101710042748 UL80 Proteins 0.000 claims 10
- 101700020292 V2 Proteins 0.000 claims 10
- 230000003612 virological Effects 0.000 claims 7
- 239000003814 drug Substances 0.000 claims 6
- 229940079593 drugs Drugs 0.000 claims 6
- 102000018358 Immunoglobulins Human genes 0.000 claims 5
- 108060003951 Immunoglobulins Proteins 0.000 claims 5
- 210000002966 Serum Anatomy 0.000 claims 5
- 241000700605 Viruses Species 0.000 claims 5
- 230000001225 therapeutic Effects 0.000 claims 5
- 108060009635 YSP2 Proteins 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 3
- 241000701447 unidentified baculovirus Species 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 230000002688 persistence Effects 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 230000017610 release of virus from host Effects 0.000 claims 2
- 206010018987 Haemorrhage Diseases 0.000 claims 1
- 210000001331 Nose Anatomy 0.000 claims 1
- 101710043203 P23p89 Proteins 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 230000001809 detectable Effects 0.000 claims 1
- 230000011132 hemopoiesis Effects 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 230000001506 immunosuppresive Effects 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 230000001681 protective Effects 0.000 claims 1
- 239000011251 protective drug Substances 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
- 241001673669 Porcine circovirus 2 Species 0.000 abstract 6
- 230000002519 immonomodulatory Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Abstract
DC60 (01/07/58) การประดิษฐ์นี้เกี่ยวข้องกับการใช้องค์ประกอบก่อภูมิคุ้มกันซึ่งประกอบรวมด้วยแอนติเจน เซอร์โคไวรัสสุกรไทป์ 2 (PCV2) สำหรับป้องกัน และรักษาการติดเชื้อ PCV2 ที่ไม่แสดงอาการใน สัตว์ ที่นิยมคือ สุกรซึ่งยังไม่โตเต็มที่ (pigs) แก้ไขบทสรุปการประดิษฐ์ 1/07/2558 การประดิษฐ์นี้เกี่ยวข้องกับการใช้องค์ประกอบก่อภูมิคุ้มกันซึ่งประกอบรวมด้วยแอนติเจน เซอร์โคไวรัสสุกรไทป์ 2 (PCV2) สำหรับป้องกัน และรักษาการติดเชื้อ PCV2 ที่ไม่แสดงอาการใน สัตว์ ที่นิยมคือ สุกรซึ่งยังไม่โตเต็มที่ (pigs) ------------------------------------------------------------------- การประดิษฐ์นี้เกี่ยวข้องกับการใช้สารผสมก่อภูมิคุ้มกันซึ่งประกอบรวมด้วยแอนติเจนเซอร์ โคไวรัสสุกรไทป์ (PCV2) สำหรับป้องกัน และรักษาการติดเชื้อ PCV2 ที่ไม่แสดงอาการในสัตว์ ที่ นิยมคือ สุกรยังโตไม่เต็มที่ (Pigs) สิทธิบัตรยา DC60 (01/07/15) This invention involves the use of an immunomodulatory constituent consisting of an antigen. Swine zircovirus type 2 (PCV2) for prevention and treat asymptomatic PCV2 infection in animals, preferably immature pigs (pigs). Swine zircovirus type 2 (PCV2) for prevention and treat asymptomatic PCV2 infection in animals, preferably in pigs that have not yet matured (pigs). ---------------------------------------- This invention involves the use of a mixture of Immunity, which includes antigens Swine coviral type (PCV2) for prevention and treat asymptomatic PCV2 infection in animals, the most popular being pigs.
Claims (3)
Publications (3)
Publication Number | Publication Date |
---|---|
TH99635A TH99635A (en) | 2009-12-30 |
TH99635B TH99635B (en) | 2009-12-30 |
TH65953B true TH65953B (en) | 2018-10-31 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rauw et al. | Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old | |
JP7088835B2 (en) | Porcine circovirus type 3 immunogenic composition, its production method, and its usage method | |
Sánchez-Cordón et al. | Evaluation of protection induced by immunisation of domestic pigs with deletion mutant African swine fever virus BeninΔMGF by different doses and routes | |
Sharma et al. | Infectious bursal disease virus of chickens: pathogenesis and immunosuppression | |
RU2520759C2 (en) | Preventing and treating subclinical form of porcine circovirus diseases (pcvd) | |
Cao et al. | Poly (I: C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs | |
KR101554080B1 (en) | Bovine viral diarrhea virus type 1b vaccine compositions and methods | |
RU2008102930A (en) | METHODS FOR ADMINISTRATION OF VACCINES, NEW CALICIVIRUSES OF CAT AND TREATMENT OPTIONS FOR IMMUNIZATION OF ANIMALS AGAINST CATVARVOIRUS OF CAT AND VIRTUAL VIRGIN OF CAT | |
WO2014139359A1 (en) | Hepatitis b vaccine | |
Gao et al. | Plasmid pcDNA3. 1-s11 constructed based on the S11 segment of grass carp reovirus as DNA vaccine provides immune protection | |
Dou et al. | Maternal antibody induced by recombinant gp85 protein vaccine adjuvanted with CpG-ODN protects against ALV-J early infection in chickens | |
US20230330214A1 (en) | Improved dna vaccine for sars-cov-2 | |
Annamalai et al. | Prophylactic potential of resiquimod against very virulent infectious bursal disease virus (vvIBDV) challenge in the chicken | |
KR101442493B1 (en) | An attenuated porcine epidemic diarrhea virus, vaccine composition comprising the same | |
US9872895B2 (en) | TLR5 ligands, therapeutic methods, and compositions related thereto | |
Umar et al. | Chicken infectious anaemia, an immunosuppressive disease of poultry birds | |
TH65953B (en) | Prevention and treatment of asymptomatic PCVD | |
TH99635A (en) | Prevention and treatment of asymptomatic PCVD | |
KR20160093047A (en) | Vaccine against porcine circo virus type 2 | |
JP7475828B2 (en) | A seasonal influenza vaccine capable of inducing virus-specific antibodies in the nasal cavity | |
AU2012303887B2 (en) | Use of the PACAP as a molecular adjuvant for vaccines | |
Lee et al. | Porcine interferon-α linked to the porcine IgG-Fc induces prolonged and broad-spectrum antiviral effects against the foot-and-mouth disease virus | |
US11319382B1 (en) | Methods for producing and using IgY antibodies targeting the middle east respiratory syndrome coronavirus spike protein to treat or prevent MERS-CoV infection | |
TW202203970A (en) | Igy immunoglobulins targeting coronavirus, methods of preparing same, and methods of using same | |
CN116139262A (en) | Respiratory syncytial virus immune composition and preparation method and application thereof |